Client Name

Hoechst Pakistan Limited

Faculty Advisor

Dr. Hassan Mahmood

SBS Thought Leadership Areas

Entrepreneurship and Innovation

SBS Thought Leadership Area Justification

Changing Trends in Diabetes Management directly addresses the urgent healthcare challenges in Pakistan by identifying innovative approaches for pharmaceutical companies to expand their portfolios, adopt new technologies, and develop affordable advanced therapies. The report outlines strategic recommendations such as licensing agreements for GLP-1 agonists, localized manufacturing, digital health integration, and awareness campaigns, all of which fall under entrepreneurial problem-solving and innovation-driven growth.

The alignment with Entrepreneurship and Innovation is clear because the study emphasizes creating new market opportunities, reshaping supply chains, and fostering partnerships that bring advanced solutions to an underserved population. It highlights not only the medical aspects of diabetes care but also the entrepreneurial potential for Hoechst Pakistan Limited to pioneer affordable innovation in a competitive and resource-constrained environment.

By combining research insights with actionable strategies, the project reflects how entrepreneurial thinking and innovation can improve healthcare accessibility while simultaneously generating sustainable business value. In this way, the project exemplifies how business innovation can be harnessed to solve pressing societal issues, which is at the core of this thought leadership area.

Aligned SDGs

GOAL 3: Good Health and Well-being

Aligned SDGs Justification

Changing Trends in Diabetes Management focuses on improving healthcare accessibility and outcomes for people living with diabetes in Pakistan, a population that is projected to grow substantially in the coming years. By recommending strategies such as expanding access to advanced therapies like GLP-1 agonists, fostering licensing partnerships, and localizing manufacturing, the project addresses critical barriers to treatment affordability and availability. These measures directly contribute to SDG 3’s aim of ensuring healthy lives and promoting well-being for all at all ages.

The alignment is particularly strong because the project not only examines the medical and therapeutic side of diabetes management but also integrates business innovation to improve patient access. This dual focus ensures that sustainable business growth and public health improvement go hand in hand. Moreover, the inclusion of digital health integration and awareness campaigns reflects SDG 3’s emphasis on prevention, treatment, and education as key drivers of better health outcomes.

In essence, the project contributes to SDG 3 by creating a framework where innovative business strategies enable wider healthcare access, ultimately improving quality of life for individuals with diabetes in Pakistan.

NDA

No

Abstract

Pakistan faces a rapidly escalating diabetes epidemic, with approximately 33 million adults currently living with diabetes — one of the highest national prevalence rates globally. This surge has created both a pressing public health challenge and a substantial commercial opportunity in diabetes management. Despite advances in pharmacological treatments and technology worldwide, Pakistan’s diabetes care landscape remains constrained by high costs, limited access to newer therapies, regulatory delays, and uneven healthcare infrastructure. This report provides a comprehensive analysis of global and Pakistani diabetes markets, identifying critical gaps in treatment adherence, affordability, and technology adoption. It incorporates primary insights from healthcare professionals on prescribing patterns and barriers faced locally. Detailed market data, including medicine pricing comparisons across major pharmaceutical companies, reveal disparities in drug availability and cost that directly influence treatment choices. Strategically, the report recommends Hoechst Pakistan Limited develop patient-centric diabetes management solutions tailored to local needs, improve accessibility to advanced medicines such as SGLT2, and invest in awareness and education campaigns. It also highlights opportunities in expanding device accessibility and fostering collaborative partnerships. Strong emphasis is placed on proactive regulatory engagement with DRAP to navigate Pakistan’s complex market and facilitate launch of new medicines. Grounded firmly in Pakistan’s socio-economic and healthcare realities, this study aims to equip Hoechst Pakistan Limited with actionable strategies to lead the diabetes care sector and improve outcomes for millions of patients.

Document Type

Restricted Access

Document Name for Citation

Changing Trends in Diabetes Management

Download

Share

COinS